271980.KO Jeil Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
8,710 KRW
Close of Nov 5, 2026
8,480 19,290
Market cap
KRW 128B
P/E
13.7x
P/B
0.62x
ROE
-8.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 271980.KO undervalued?

Graham number
Price8,710
Graham value14,126
Discount38.3%

271980.KO trades 38.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jeil Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Jeil Pharmaceutical Co Ltd yet.

Jeil Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jeil Pharmaceutical Co Ltd

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea and internationally. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company exports its products. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

Full company profile